Sheel Biotech IPO GMP & Review: Should You Apply or Avoid?

Check Expert’s Verdicts on Sheel Biotech IPO

Sheel Biotech’s IPO is open for bidding from 30th September 2025 to 3rd October 2025. It is a book-building IPO of ₹34.02 crores, comprising an entirely fresh issue of ₹0.54 crores. The problem will be listed on NSE and SME on its tentative listing date, 8th October 2025. 

Sheel Biotech IPO Details 

The Sheel Biotech IPO date is fixed between 30th September 2025 and 3rd October 2025. The face value of Sheel Biotech’s IPO shares is ₹10 per share, and the IPO price is set between ₹59 and ₹63 per share.

Skyline Financial Services Private Limited is the registrar of the Sheel Biotech IPO and is responsible for managing the allotment process and initiating refunds. Check out the latest IPO details in the table below. 

Sheel Biotech IPO Share Reservation

Sheel Biotech’s IPO is a book-building IPO of ₹34.02 crores, comprising an entirely fresh issue of 0.54 crore shares, which will be listed on the NSE and SME Exchange. Furthermore, SEBI has specified the share reservation criteria for different investor categories. 

Sheel Biotech IPO GMP Grey Market Premium

GMP is the gap between the price band of the issue and the price at which company shares are currently trading in the grey market. Would you like to receive live updates on the Sheel Biotech IPO? If yes, then you’ve reached the right spot. Check the table below to learn about the GMP trends.

As of September 26, 2025, Sheel Biotech’s IPO GMP stands at ₹0 per share, indicating that the share is likely to list at ₹63 on its tentative listing date, October 6, 2025.

GMP data is subject to change based on market trends and sentiments. Please verify the live GMP status before applying for the Sheel Biotech GMP. Stay informed with Univest to know about real-time insights on IPOs and their GMP trends. 

Sheel Biotech IPO GMP Review

Check out the detailed Sheel Biotech GMP IPO review for a thorough understanding of its potential to report listing gains on 8th October 2025. The Sheel Biotech IPO review below will help you invest effectively to avoid significant losses. Explore more to make informed investment decisions on this IPO. 

Financial Health

Assess a company’s financial performance to know about its ability to sustain a competitive edge. Therefore, it is crucial to understand the business’s financial growth margins and declines before applying for the Sheel Biotech IPO.

Sheel Biotech Limited’s revenue increased by 15.41% from ₹80.19 crore in March 2023 to ₹ 92.55 crore in March 2024. Moreover, the company’s PAT rose by 106.89% from ₹5.08 crores to ₹10.51 crores.

Sheel Biotech Limited’s IPO has demonstrated consistent revenue growth, indicating that the company is financially stable. Moreover, brokers, investors, and RAs have a positive outlook for the Sheel Biotech IPO on its tentative listing date,6th October 2025.  

Technical Analysis

Several technical indicators are available to assess a company’s potential to deliver returns. Use the parameters mentioned below to analyse the technical aspects of the Sheel Biotech IPO.

The P/E ratio of Sheel Biotech Limited’s share is 8.96, and its Earnings Per Share (EPS) stands at 7.03. Thus, the Sheel Biotech Limited IPO can deliver gains on its tentative listing date, 8th October  2025. 

Note: The data, as mentioned above, is taken from authentic sources and highlights pre-issue information. The PE ratio and EPS of Sheel Biotech Limited are subject to change following the IPO. Refer to the table below for post-issue updates on these two metrics. 

Sheel Biotech IPO Subscription Status

The Sheel Biotech IPO is scheduled to open for bidding on September 30, 2025. The subscription status for this IPO is yet to be announced. Stay informed on this passage to check the live Sheel Biotech IPO subscription status. 

About Sheel Biotech Limited

Sheel Biotech Limited was established in November 1991. Sheel Biotech Limited specialises in biotechnology, floriculture, greenhouses, and organic projects. The company grows and supplies various plants for field crops, fruits, vegetables, and ornamentals through tissue culture and organic farming. The company manufactures and maintains greenhouses, provides farmer services, and offers training through FPOs. They also deliver landscaping services to the government and private sectors. The company holds ISO 9001:2015, 14001:2015, and 45001:2018 certifications, reflecting its commitment to quality, environmental responsibility, and safety. The company’s Research and Development laboratory is recognised by the Department of Biotechnology (DBT) and the Department of Science and Technology (DST) of the Government of India.

Sheel Biotech Limited Financials

The company’s financial analysis is essential before applying for the Sheel Biotech  IPO. Refer to the table to learn about Sheel Biotech Limited’s financial information. 

Explanation

Sheel Biotech Limited’s revenue increased by 15.41% from ₹80.19 crore in March 2023 to ₹ 92.55 crore in March 2024. Moreover, the company’s PAT rose by 106.89% from ₹5.08 crores to ₹10.51 crores.

Sheel Biotech IPO Bidding Requirements

Investors can bid for a minimum of 3,200 shares and in multiples of 1,600 thereof. The following table represents the minimum and maximum investments by individual investors (retail) and HNI in terms of shares and amount.

Sheel Biotech’s IPO has reserved lot sizes for different investor categories. Refer to the table below to view the requirements for applying to this IPO.

Use the lot size calculator to find how many shares you should apply for!

Sheel Biotech IPO Promoter Holding

Refer to the table below to review the holdings of Sheel Biotech Limited’s promoters: Sanjay Singhania, Ajay DD Singhania, Bajrang Bothra, Laxmi Pat Bothra and Nikhil Bothra.

Note: The value will be calculated using Equity Dilution = Share Holding Pre-Issue –  Share Holding Post-Issue.

Aim of the Sheel Biotech IPO

The primary aim of the Sheel Biotech IPO is to raise ₹34.02 crore. On the other hand, Sheel Biotech has decided to utilise these funds in different ways. Explore some of the secondary objectives for the Sheel Biotech IPO.

• To Capital Expenditure Requirement
• To Working Capital Requirement
• To General Corporate Purposes

Should I Invest in the Sheel Biotech IPO?

Explore the pros and cons of Sheel Biotech to know whether you should apply or avoid the issue. These pros and cons may help you understand the IPO’s efficiency in generating profits in the coming decades. 

Pros of Sheel Biotech IPO

• The company offers a wide range of products across agriculture, horticulture, and floriculture.
• The company has eco-friendly practices and a focus on organic, sustainable farming.
• The company is skilled in biotechnology, organic farming and greenhouse management.  

Cons of Sheel Biotech IPO

• The company has a high minimum investment and a lot size
• The company has a listing on the SME platform 
• A significant portion of funds is intended for working capital and capital expenditure.

How to Apply for the Sheel Biotech IPO?

Please follow the steps outlined below to apply for a position at Sheel Biotech Limited.

• Step 1: Conduct thorough research on the Sheel Biotech IPO, including GMP, subscription status, issue size, lot size, and other relevant details. 
• Step 2: Open a demat account with Univest to gain real-time insights into GMP and subscription status. You can also use your previous demat account by navigating to the IPO section. 
• Step 3: Place a bid for two lots of 4,000 shares, valued at ₹2,52,000.
• Step 4: You will receive a mandate request after making a bid. Approve the request to proceed further.    

Note: You can apply for the Sheel Biotech IPO from more than one demat account to increase your chances of allotment. 

How to Check Sheel Biotech IPO Allotment Status?

You can check whether the Sheel Biotech IPO allotment has been completed in various ways. These include NSE and the registrar portal. Refer to the steps below to check your allotment status online.

Check On BSE

• Visit the BSE Official Website.
• Navigate to the IPO Allotment Section. 
• Select Equity as the issue type. 
• Choose the Sheel Biotech IPO.  
• Choose whether to proceed with the PAN number or the application number. 
• Submit your details to get the allotment status online. 

Check On the Registrar Portal

• Visit the registrar portal.
• Click on the allotment option.
• Fill in the required details.
• Click on the submit button to know your Sheel Biotech IPO allotment status.

Let’s Wrap

Sheel Biotech’s IPO is a fresh issue of shares worth ₹34.02 crore. The shares of Sheel Biotech Limited will be listed on NSE and SME on its tentative listing date of 3rd October 2025. Researching the Sheel Biotech IPO, including GMP and reviews, is highly recommended to secure your ideal profitability. Brokers and investors have highlighted their pros and cons, so one must analyse them and decide accordingly.

Open a demat account on Univest now to initiate your investment journey!

FAQs on Sheel Biotech IPO

How is the Sheel Biotech IPO?

Ans. As of 26th September 2025, the Sheel Biotech IPO GMP (Grey Market Premium) stands at ₹0. It indicates that the estimated listing price could be ₹63.00 per share. It is a book-building IPO of ₹34.02 crore, comprising an entirely fresh issue of ₹0.54 crore. The face value of each share of Sheel Biotech Limited is ₹10 per share.

What is the IPO price of Sheel Biotech?

Ans. The Sheel Biotech IPO price is set between ₹59 to ₹93 per share.  Retail investors can apply for a minimum of 2 lots, each consisting of 4,000 shares, worth ₹2,52,000. Moreover, HNIs are required to bid for a minimum of 3 lots (6,000 shares) worth ₹3,78,000.

Is the Sheel Biotech IPO a good investment?

Ans. Sheel Biotech Limited’s revenue increased by 15.41% from ₹80.19 crore in March 2023 to ₹ 92.55 crore in March 2024. Moreover, the company’s PAT rose by 106.89% from ₹5.08 crores to ₹10.51 crores.

Who is the registrar of the Sheel Biotech IPO?

Ans. Skyline Financial Services Private Limited is the registrar of the Sheel Biotech IPO, responsible for managing the allotment procedure and initiating refunds. For any queries regarding the Sheel Biotech allotment and refund, you can contact Skyline Financial Services Private Limited at compliances@skylinerta.com    or 02228511022.

What is the issue size of the Sheel Biotech IPO?  

Ans. Sheel Biotech’s IPO is a book-building IPO of ₹34.02 crore, comprising an entirely fresh issue of 0.54 crore shares. Moreover, the IPO is set to open on 30th September 2025 and will be closed on 3rd October 2025. 

Disclaimer: The above information is compiled from authentic sources and is just for informational purposes. To have detailed information about the Sheel Biotech IPO, download the Sheel Biotech IPO RHP and the Sheel Biotech IPO DRHP. Conduct thorough research before investing in IPOs to minimise the risk of significant losses. You can also consult your financial advisor.

Upcoming IPOs

Current & Previous IPOs

Read Our Articles on the Best Stocks

Tech Stocks in India to Invest in 2025 | Tech Sector Stocks 

Best Battery Stocks in India to Invest in 2025 | Battery Sector Stocks 

Best Shipping Stocks in India to Invest in 2025 | Shipping Sector Stocks 

Paint Stocks in India to Invest in 2025 | Paint Sector Stocks 

Paper Stocks in India to Invest in 2025 | Paper Sector Stocks 

Best Semiconductor Stocks in India 2025 

Best Large Cap Stocks in India 2025 

Green Energy Penny Stocks

Best Cement Stocks To Invest in India

Also Explore

Univest Screeners

Explore Webstories on Univest 

1. Best Time To Buy Dividend Stocks

2. How RBI Policies Affect Dividend Stocks

3. Can Dividend Stocks Beat Inflation

4. What Is The Dividend Aristocrat List

5. Which Indian Psus Offer The Best Dividends

6. Large Cap Vs Small Cap Dividend Stocks